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Abstract
Background: Epidemiological studies suggest a non-monotonic effect of alcohol consumption on
cardiovascular risk, while there is strong evidence concerning the involvement of homocysteine
levels on thrombosis. The aim of this work was to evaluate the association between usual ethanol
consumption and homocysteine levels, in cardiovascular disease free adults.
Methods: From May 2001 to December 2002 we randomly enrolled 1514 adult men and 1528
women, without any evidence of cardiovascular disease, stratified by age – gender (census 2001),
from the greater area of Athens, Greece. Among the variables ascertained we measured the daily
ethanol consumption and plasma homocysteine concentrations.
Results: Data analysis revealed a J-shape association between ethanol intake (none, <12 gr, 12 –
24 gr, 25 – 48 gr, >48 gr per day) and total homocysteine levels (mean ± standard deviation) among
males (13 ± 3 vs. 11 ± 3 vs. 14 ± 4 vs. 18 ± 5 vs. 19 ± 3 µmol/L, respectively, p < 0.01) and females
(10 ± 4 vs. 9 ± 3 vs. 11 ± 3 vs. 15 ± 4 vs. 17 ± 3 µmol/L, respectively, p < 0.01), after controlling
for several potential confounders. The lowest homocysteine concentrations were observed with
ethanol intake of < 12 gr/day (Bonferroni α* < 0.05). No differences were observed when we
stratified our analysis by type of alcoholic beverage consumed.
Conclusion: We observed a J-shape relationship between homocysteine concentrations and the
amount of ethanol usually consumed.
Introduction
Alcoholic beverages are widely consumed throughout the
world and it has long been known that heavy alcohol con-
sumption is hazardous to various body organs. In several
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causes of preventable deaths, after smoking [1]. However,
there is now also substantial evidence that the intake of
light to moderate amounts of ethanol is associated with
reduced morbidity and mortality from several cardiovas-
cular conditions, particularly coronary heart disease
(CHD) [2]. The interpretation of these beneficial effects
has been extensively discussed and it has been suggested
that the effects on cardiovascular disorders might not be
due to ethanol per se but to other confounding factors [3].
Low to moderate ethanol consumption has been associ-
ated with reduced mortality, primarily due to a reduction
in coronary heart disease (CHD). Conversely, heavy
drinking increases mortality, mainly due to haemorrhagic
stroke and non-cardiovascular diseases [4,5].
Some investigators consider increased homocysteine lev-
els as an independent risk factor of cardiovascular disease,
and its involvement in mechanisms of thrombosis has
well been documented [6,7]. Moreover, other studies sug-
gest that an elevated plasma total homocysteine concen-
tration increases the risk associated with some of the
conventional cardiovascular risk factors [8,9]. However,
there are findings that do not confirm or recognize homo-
cysteine importance in actually causing coronary artery
disease, while recent studies have considered homo-
cysteine more as a result than a cause of arteriosclerosis,
especially due to the confounding effect of various nutri-
ents and other lifestyle-related factors, including alcohol
drinking [10-13].
We therefore studied the relation between amount of eth-
anol consumption and homocysteine levels, in 3042
adults enrolled in the ATTICA Study.
Subjects and Methods
Study population
The "ATTICA" study [14] is a health and nutrition survey,
which is being carried out in the province of Attica
(including 78% urban and 22% rural areas), where Ath-
ens is the metropolis. The sampling was random, multi-
stage and it was based on the age – sex distribution of the
province of Attica, provided by the National Statistical
Service (census of 2001). Also, all people living in institu-
tions were excluded from the sampling, and we enrolled
only one participant per household. From May 2001 to
December 2002, 4056 inhabitants from the above area,
who had no clinical symptoms or signs of cardiovascular
or any other atherosclerotic disease (as assessed by the
physical examination and reported medical history), nor
evidence of chronic viral infections, were randomly
selected to enter into the study. None of the participants
was under current or chronic use of certain drugs that
influence homocysteine levels, like methotrexate, tri-
methoprin, cholestyramine and cyclosporine. Moreover,
subjects did not have cold or flu, acute respiratory infec-
tion, dental problems or any type of surgery in the preced-
ing week. Of the 4056 inhabitants, 1518 men (46 ± 13
years old) and 1524 (45 ± 13 years old) women agreed to
participate (75% participation rate). Participants were
interviewed by trained personnel (cardiologists, general
practitioners, dieticians and nurses) who used a standard
questionnaire.
The selected sample was population-based and reflecting
the underlying population with respect to sex, age and res-
idence. The number of the participants was determined by
power analysis and chosen to evaluate greater than 0.5
standardised differences between ethanol groups and
homocysteine levels, with statistical power > 0.80 at <
0.05 probability level (P-value).
Measurements
The questionnaire included demographic characteristics
(age, sex, mean annual income and years of school),
detailed medical history and lifestyle habits, such as food
items consumed, smoking habits and physical activity
status.
Dietary intake during the year before enrolment was
assessed through a semi-quantitative food frequency
questionnaire provided by the EPIC-Greece Study. The
questionnaire was administrated in person by specially
trained dieticians and has been validated [15]. The daily
ethanol intake was assessed in a 7-day food record. All
alcoholic beverages consumed, i.e. wine, beer, whisky, tra-
ditional alcoholic drinks, like "retsina" or "tsipouro", and
other spirits were recorded and daily ethanol intake (in
grams) was calculated. For the presentation of our find-
ings we categorized ethanol intake into five groups: (a) no
ethanol intake, (b) low (< 12 gr), (c) moderate (12 – 24
gr), (d) high (25 – 48 gr) and (e) very high (>48 gr). More-
over, the frequency of consumption of several food
groups was quantified approximately in terms of the
number of times per month the food was consumed.
Regarding the rest of the investigated parameters the edu-
cational level of the participants (as an index of social sta-
tus) was measured in years of school. Information about
smoking habits was collected using a standardized ques-
tionnaire developed for the Study. Current smokers were
defined as those who smoked at least one cigarette per
day. Former smokers were defined as those who had
stopped smoking more than one year previously. The rest
of the participants were defined as non smokers. For the
multivariate statistical analyses cigarette smoking was
quantified in pack-years (cigarette packs per day × years of
smoking), adjusted for a nicotine content of 0.8 mg / cig-
arette. All participants were classified at entry according to
their habitual physical activity. Class 1 were sedentary,Page 2 of 7
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during a substantial part of the day; and class 3 performed
hard physical work much of the time. Classification was
based on the responses to questions about the occupation
and usual activities, including part-time jobs and notable
non-occupational exercise [14]. Body mass index was
measured as weight (in kilograms) divided by standing
height (in meters squared). Obesity was defined as body
mass index > 29.9 Kg / m2.
Blood samples were collected from the antecubital vein
between 8 to 10 a.m., in a sitting position after 12 hours
of fasting and avoiding of ethanol. For the determination
of plasma fibrinogen blood was anticoagulated with 3.8%
trisodium citrate (9:1 vol/vol) and cooled on ice until cen-
trifugation. For determination of homocysteine, blood
was collected in a cool vacutainer containing EDTA,
which was stored on ice for a maximum of 2 hours till the
centrifugation at 3000 g for 5 minutes at 4°C. Plasma
homocysteine levels were measured with an automatic
Abott Axsym analyzer, which is based on the technology
of polarized immunofluorescence. The intra and inter-
assay coefficients of variation of homocysteine did not
exceed 5%.
Arterial blood pressure was automatically measured at the
end of the physical examination with subject in sitting
position. Hypertension was defined as a systolic blood
pressure >/= 140 mmHg, a diastolic blood pressure >/= 90
mmHg, or the use of any antihypertensive medication;
hypercholesterolemia was defined as total cholesterol lev-
els greater than 220 mg/dl or the use of lipid lowering
agents and diabetes mellitus as a fasting blood glucose >
125 mg/dl or the use of antidiabetic medication.
Statistical analysis
Continuous variables are presented as mean values ±
standard deviation, while qualitative variables are pre-
sented as absolute and relative frequencies. Associations
between categorical variables were tested by the use of
contingency tables and the calculation of chi-squared test.
Comparisons between normally distributed continuous
variables and categorical variables were performed by the
calculation of Student's t-test and multi way Analysis of
co-Variance (multi-ANCOVA), after controlling for
homoscedacity and various potential confounders. In the
case of asymmetric continuous variables the tested
hypotheses were based on the calculations of non-para-
metric tests, such as Mann – Whitney and Kruskal – Wal-
lis. Kolmogorov-Smirnov criterion assessed normality of
continuous variables. Finally, correlations between con-
tinuous variables were tested through multiple regression
analysis after the adjustment for the potential confound-
ers and interactions. The J- shape association between the
exposure variable (ethanol intake) and homocysteine lev-
els was illustrated by connecting the mean values of the
investigated parameters using 3rd order interpolating
polynomials.
All reported P-values are based on two-sided tests and
compared to a significance level of 5%. However, due to
multiple significance tests we used the Bonferroni correc-
tion (since the number of comparisons was less than ten)
in order to account for the increase in Type I error. SPSS
11.0 software (SPSS Inc. 2002, Illinois, USA) was used for
all the statistical calculations.
Results
Thirty four percent of males and 62% percent of females
reported ethanol abstinence within the recorded 7-day
period (p < 0.001). In addition, 37% of males and 33% of
females consumed < 12 gr of ethanol per day, 16% of
males and 4% of females consumed 12 – 24 gr of ethanol
per day, and 13% of males and 1% of females consumed
> 24 gr of ethanol per day (1.6% of males and 0.4% of
females consumed > 48 gr/d), during the preceding week.
Furthermore, middle-aged male participants (45 – 65
years old) consumed higher quantities of ethanol com-
pared to younger (< 45 years) or older individuals (18 ±
16 vs. 12 ± 14 vs. 15 ± 16 gr of ethanol per day, respec-
tively, p = 0.002), while no statistically significant differ-
ences were observed between ethanol consumption and
age, in females (9 ± 13 vs. 11 ± 12 vs. 12 ± 14 gr of ethanol
per day, respectively, p = 0.391). Ethanol intake comes
from wine in 65% of men and 77% of women, from beer
in 22% of men and 11% of women and from spirits or
other drinks 13% of men and 12% of women. Further,
descriptive characteristics of the studied population by
ethanol consumption level are presented in Table 1. By
the exception of years of school (p = 0.02) and prevalence
of hypertension (p = 0.01) no other associations were
observed between ethanol intake and smoking habits,
prevalence of hypercholesterolemia, diabetes and obesity.
Homocysteine values were higher in males as compared
to females (14.5 ± 6 vs. 10.8 ± 3.5 µmol/L, p < 0.001). The
10th percentile for men was 8.6 µmol/L and for women
6.8 µmol/L, while the 90th percentiles were 18 µmol/L and
14 µmol/L, for men and women, respectively. Due to the
significant differences observed between genders in
homocysteine levels, all the following analyses will be
gender-specific.
Unadjusted analysis revealed a J-shape association
between ethanol quantities consumed during the past
week (none, < 12 gr, 12 – 24 gr, 25 – 48 gr, >48 gr of eth-
anol per day) and homocysteine levels in both males (13
± 3 vs. 11 ± 3 vs. 14 ± 4 vs. 18 ± 5 vs. 19 ± 3 µmol/L, respec-
tively, p < 0.01) and females (10 ± 4 vs. 9 ± 3 vs. 11 ± 3 vs.
15 ± 4 vs. 17 ± 3 µmol/L, respectively, p < 0.01). Post hocPage 3 of 7
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levels were observed in people who reported moderate
daily ethanol intake of <12 gr (Bonferonni α = 0.02 for
males and α = 0.02 for females). No differences were
observed when we stratified our analysis by alcoholic bev-
erages primarily consumed. Figure 1 illustrates the
observed J-shape association between ethanol intake and
homocysteine levels in males and females.
However, since several potential confounders may influ-
ence the relationship between ethanol intake and homo-
cysteine concentration we repeated our analysis after
taking into account age, gender, pack-years of smoking,
presence of hypertension, hypercholesterolemia, and dia-
betes, body mass index, fruits and vegetables consump-
tion, especially leafy green vegetables, legumes, citrus
fruits and juices that are reached in folic acid, as well as
years of school. Multivariate regression analysis showed
that <12 gr/d ethanol intake was inversely associated with
homocysteine levels (b-coefficient = -0.5, p = 0.02) as
compared to no consumption. On the other hand,
increased ethanol intakes, i.e. 12 – 24 gr/d, 24 – 48 gr/d
or > 48 gr/d were positively associated with homocysteine
concentration (b-coefficient = 1.2, p = 0.03, b-coefficient
= 1.8, p = 0.02 and b-coefficient = 1.9, p = 0.02, respec-
tively). No differences were observed when we stratified
our analysis by gender.
Discussion
The results of the present study revealed a J-shape associa-
tion between ethanol consumption and homocysteine
levels, of a large, random and population representative
sample, free of cardiovascular disease. The lowest values
of homocysteine were observed in daily ethanol intake of
less than 12 gr, both in men and women and remained
significant after adjustment for several potential
confounders.
Our results are in line with that of some other studies. For
example, De Bree et al. [16] observed lower homocysteine
concentrations at higher levels of ethanol consumption,
with non drinkers having a (geometric) mean homo-
cysteine of 14.2 µmol/L, compared to 13.9 µmol/L in
drinkers of ≤ 20 gr ethanol/ day, 12.5 µmol/L in drinkers
of between 20 and 40 gr/day and 13.1 µmol/L in drinkers
of ≥ 40 gr / day. In our study, the lowest homocysteine
concentrations were observed with ethanol intakes <12 gr
/day. This difference between our and the previous study
may attribute to the type of alcoholic beverage consumed,
since in the study of Bree et al. beer was the main alcoholic
drink, while in our study it was wine. In another study the
most positive association of ethanol (from beer consump-
tion) on homocysteine levels was observed at ethanol
intakes 4 to 14 gr/d [17]. Another study in severely obese
patients revealed a U-shaped association between homo-
cysteine concentrations and the amount of ethanol con-
sumption [18]. In particular, the most beneficial effect
was observed with consumption of < 100 gr ethanol/
week and especially in red wine consumers, compared to
subjects who consumed white wine, beer or spirits. How-
ever, the lower homocysteine concentrations in those
consuming less than 100 gr ethanol/ week were not signif-
icant after controlling for serum folate concentration.
Finally a study in elderly subjects also found a J-shape
relation, with nondrinkers and subjects consuming ≥ 60
drinks/ month, showing higher homocysteine
Table 1: Descriptive characteristics of study's participants by alcohol intake, and by gender
Daily ethanol intake
Males None < 12 gr/d 12 – 24 gr/d 25 – 48 gr/d > 48 gr/d
Current smoking 39% 54% 43% 49% 54%
Physical inactivity 62% 56% 67% 69% 64%
Years of school (SD) 14(4) 13(4) 11(6) 11(4)** 9(4)**
Hypertension 28% 37%** 39%** 45%** 44%**
Hypercholesterolemia 33% 34% 44% 39% 34%
Diabetes 11% 11% 9% 9% 7%
Obesity 22% 24% 23% 19% 24%
Females
Current smoking 38% 25% 32% 37% 30%
Physical inactivity 64% 75% 62% 57% 80%
Years of school (SD) 13(4) 12(4) 11(3)* 10(4)** 8(3)**
Hypertension 17% 28%** 22% 22% 26%**
Hypercholesterolemia 28% 35% 32% 37% 40%
Diabetes 8% 10% 12% 6% 6%
Obesity 18% 15% 12% 17% 20%
** Bonferroni α < 0.01 and * α < 0.05 for the comparisons between ethanol intake and no intake groups.Page 4 of 7
(page number not for citation purposes)
Nutrition & Metabolism 2004, 1:9 http://www.nutritionandmetabolism.com/content/1/1/9Homocysteine levels by daily ethanol intake in males (upper figure) and females (power figure) (continuous line is a 3rd order interpolating polynomial)Figure 1
Homocysteine levels by daily ethanol intake in males (upper figure) and females (power figure) (continuous line is a 3rd order 
interpolating polynomial)Page 5 of 7
(page number not for citation purposes)
Nutrition & Metabolism 2004, 1:9 http://www.nutritionandmetabolism.com/content/1/1/9concentrations, compared to those consuming ≤ 60
drinks/ month [19]. However, the interpretation of the
results from the previous study is difficult because the
total amount of ethanol ingested was not calculated.
On the contrary, there are several studies that have shown
a linear relationship between ethanol intake and homo-
cysteine levels. For example, Folsom et al. [20] in a study
of middle-aged men and women showed a positive asso-
ciation of ethanol on homocysteine. However, he studied
very low intakes of ethanol, ranging from 27 to 47 gr/
week, and this may be the reason why a J -shaped associ-
ation was not observed. According to our findings, a sig-
nificant positive association was observed at much higher
intakes (i.e. 84–168 gr/week). Another study in young
women (aged 15–44) [21] showed that those consuming
>7 drinks/ week were 90% more likely to have elevated
homocysteine levels (> 10 µmol/l), compared to those
who did not consume ethanol. In the same study, subjects
consuming 1–7 drinks/week had the same homocysteine
levels with those that didn't consume, supporting, par-
tially, two relations between ethanol intake and homo-
cysteine. However, the association between ethanol and
homocysteine levels failed to achieve statistical signifi-
cance. Finally, homocysteine was positively associated
with ethanol intake in the Framingham Offspring cohort
[22] at daily intakes of more than 15 g. In this study liquor
and red wine consumption was significantly and posi-
tively associated with homocysteine. This association was
not observed with beer and white wine consumption.
Our data were analyzed according to total ethanol intake
and did not distinguish between different types of etha-
nol. Rimm et al. [23]reviewed the literature with respect to
beverage-specific effects on coronary heart disease and
could not find any systematic effects. On the contrary,
they showed that the U-shaped relation between ethanol
intake and cardiovascular disease mortality persisted in
populations with very different drinking patterns.
Although there have been many publications on this topic
since the aforementioned review, no systematic pattern or
results have emerged until now. Perhaps most notably in
this respect are the findings which suggest similar protec-
tive effects of ethanol not only in Bavaria (Germany) and
the Czech Republic, where beer is mainly consumed, but
also in Mediterranean countries, where wine is the most
popular alcoholic beverage [24]. Additionally, Greece is a
Mediterranean country, where wine is the most com-
monly used alcoholic beverage. According to our findings
as well as the recent results from the EPIC-Greece study
[25] 72% of women's total ethanol intake comes from
wine, 26% from beer and 12% from spirits. For men wine
contributes to 56% of total ethanol intake, beer 15% and
aniseed drinks 20%. Therefore our data do not support
the assumption of Mennen et al. [26] who suggested that
the inverse association between ethanol and homo-
cysteine is seen in populations which consume predomi-
nantly beer.
Chronic alcoholism has been found to be associated with
hyper-homocysteinaemia, which could attribute to dis-
turbed folate metabolism and to changes in circulating
concentrations of vitamin B12 and pyridoxal phosphate, as
well as to ethanol intake per se [27]. Finally, the dual
effect of ethanol consumption on homocysteine has also
been confirmed from data of animal studies, which clearly
show effects of excessive ethanol intake on the methio-
nine cycle [13]. Nevertheless, the finding that subjects
who do not consume ethanol have higher homocysteine
levels than light to moderate drinkers needs further inves-
tigation. Whether this fact can be attributed to ethanol per
se or to other substances of alcoholic beverages (e.g.
folate, B12, B6, betaine) remains unclear and more inter-
vention and experimental studies are necessary.
Limitations
This study as a cross-sectional one cannot establish causal
relations but only generate hypothesis for associations.
The population studied in this work is homogeneous and
may reflect lifestyle habits in similar cultures, like Western
Europe, Mediterranean etc. However, our findings could
not extrapolate into other populations without further
investigation and consideration. Also, the numbers of par-
ticipants in categories of high intake (>48 gr of ethanol /
d) were rather small, and the impression of the effects in
homocysteine levels in even higher ethanol consumption
may be misleading. Although this analysis has been
adjusted for several known confounders, we have indi-
rectly investigated the impact of serum folate and vita-
mins B6 and B12 intake (through food groups consumed)
on homocysteine concentrations. In addition, kidney
function is a strong determinant of homocysteine; how-
ever, we have not measured serum creatinine. The later
may be another limitation of our study. Additionally, mis-
reporting of ethanol consumption, due to social class can
be a potential confounder.
Conclusion
The present study supports the existence of a J-shape asso-
ciation between ethanol consumption and homocysteine
levels in both males and females, of a large, random and
population representative sample, free of cardiovascular
disease. Therefore our results indicate that daily consump-
tion of 1–2 units of ethanol is associated with lower
homocysteine concentrations and provide further evi-
dence for a variant association between ethanol intake
and coronary heart disease risk in both genders.
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